Seeking Control for Moderate-to-Severe Asthma: The Underestimated Impact of Comorbidities Along the Lifespan
Released On
March 5, 2024
Expires On
March 5, 2025
Media Type
Internet
Completion Time
60 minutes
Specialty
Allergy & Immunology, Pulmonology
Topics
Asthma
This activity is jointly provided by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC, in collaboration with Asthma and Allergy Foundation of America (AAFA).
This activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi.
Credit Available
- Physicians - maximum of 1.0 AMA PRA Category 1 Credit™
Target Audience
The primary target audience for this activity are pulmonologists, allergists/immunologists, and specialty advanced practice providers (NPs and PAs). The secondary audience for this activity are primary care physicians, and general practice NPs and PAs.
Program Overview
Severe uncontrolled asthma leads to multiple negative health and socioeconomic effects. Asthma is also associated with comorbid conditions, some driven by shared type 2 inflammatory pathophysiology, including atopic dermatitis, chronic rhinosinusitis with or without nasal polyps (CRSwNP, CRSsNP), eosinophilic esophagitis (EoE), and chronic urticaria. Some of these comorbidities may aggravate and complicate asthma management and contribute to poor treatment response. Poorly controlled asthma in children can have lasting effects on lung development as well.
Join Michael Wechsler, MD and Anju Peters, MD, who will discuss strategies to recognize and better manage moderate‐to‐severe asthma in adults and children. Our panelists will review the latest asthma guidelines, explore the evidence supporting biologic treatments, and reinforce best practices in patient-centered care.
Learning Objectives
After completing this activity, the participant should be better able to:
- Summarize the negative effects of comorbidities on asthma disease burden and the ability to achieve asthma control
- Explain the negative outcomes on lung development on the failure to achieve optimum asthma control in children
- Discuss the role of patient and caregiver preferences in the shared decision‐making process and how to align treatment priorities
Faculty
Michael E. Wechsler, MD
Professor of Medicine
Director, NJH Asthma Institute
National Jewish Health
Anju Peters, MD
Professor of Medicine
Northwestern University Feinberg School of Medicine
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physician Continuing Education
PACE designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Conflicts Of Interest
PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to PACE policies. Others involved in the planning of this activity have no relevant financial relationships.
Instructions for Participation and Credit
In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a score of 75% on the post-test.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Accreditation Support
For additional information about the accreditation of this activity, please visit https://partnersed.com.
Technical Support
For any technical issues or issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at [email protected].
PlatformQ Health Privacy Policy
By clicking “Start Activity” you are agreeing to PlatformQ Health’s privacy policy. PlatformQ Health takes your privacy very seriously. The full Privacy Policy found here (i) the types of information we collect from you when you visit our Site; (ii) how we use the information we collect; (iii) with whom and why we share it; and (iv) the choices we offer regarding our use of the information. We also describe how to contact us about our privacy practices.
Information we collect is primarily used to communicate with program participants, award CME/CE credits, manage user accounts, recommend relevant programs and perform data analysis to inform educational outcomes.
In plain English, here is what we affirm:
- You can change your registration profile at any time from our “Profile” page
- To request any of these changes without logging in, please call us at 1 (877) 394-1306 or email us at [email protected]
- You can end your association with PlatformQ Health at any time
- PlatformQ Health does not spam, nor we do we rent or sell our email list in whole or in part. Any program-related data sharing is for engagement verification and opt-in based further education
- EU citizens can request a complete record of their account and/or request to have their personal data expunged by contacting [email protected] with the subject line “Data Request”
You acknowledge and agree that by beginning this activity, you have affirmatively agreed to this Privacy Policy and consented to receiving electronic messages in conformance with this Privacy Policy. Please read the full privacy policy located at: www.platformqhealth.com/privacy-policy/